General Information of Drug Off-Target (DOT) (ID: OT6Q5M0C)

DOT Name Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5)
Synonyms EC 3.1.3.16; Bcl-XL-binding protein v68; Phosphoglycerate mutase family member 5
Gene Name PGAM5
Related Disease
Neoplasm ( )
Autoimmune hepatitis ( )
Autosomal dominant optic atrophy, classic form ( )
Bronchiolitis ( )
Chronic obstructive pulmonary disease ( )
Colorectal carcinoma ( )
Hepatitis ( )
Hepatitis A virus infection ( )
Non-small-cell lung cancer ( )
Obesity ( )
Pneumonia ( )
Pneumonitis ( )
Pulmonary fibrosis ( )
Advanced cancer ( )
Autoimmune disease ( )
Hepatocellular carcinoma ( )
Nervous system inflammation ( )
UniProt ID
PGAM5_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
3MXO; 3O0T; 5MUF; 6CNI; 6CNL; 7QAL; 7QAM; 7QAO; 7QAP
EC Number
3.1.3.16
Pfam ID
PF00300
Sequence
MAFRQALQLAACGLAGGSAAVLFSAVAVGKPRAGGDAEPRPAEPPAWAGGARPGPGVWDP
NWDRREPLSLINVRKRNVESGEEELASKLDHYKAKATRHIFLIRHSQYHVDGSLEKDRTL
TPLGREQAELTGLRLASLGLKFNKIVHSSMTRAIETTDIISRHLPGVCKVSTDLLREGAP
IEPDPPVSHWKPEAVQYYEDGARIEAAFRNYIHRADARQEEDSYEIFICHANVIRYIVCR
ALQFPPEGWLRLSLNNGSITHLVIRPNGRVALRTLGDTGFMPPDKITRS
Function
Mitochondrial serine/threonine phosphatase that dephosphorylates various substrates and thus plays a role in different biological processes including cellular senescence or mitophagy. Modulates cellular senescence by regulating mitochondrial dynamics. Mechanistically, participates in mitochondrial fission through dephosphorylating DNM1L/DRP1. Additionally, dephosphorylates MFN2 in a stress-sensitive manner and consequently protects it from ubiquitination and degradation to promote mitochondrial network formation. Regulates mitophagy independent of PARKIN by interacting with and dephosphorylating FUNDC1, which interacts with LC3. Regulates anti-oxidative response by forming a tertiary complex with KEAP1 and NRF2. Regulates necroptosis by acting as a RIPK3 target and recruiting the RIPK1-RIPK3-MLKL necrosis 'attack' complex to mitochondria.
KEGG Pathway
Mitophagy - animal (hsa04137 )
Necroptosis (hsa04217 )
TNF sig.ling pathway (hsa04668 )

Molecular Interaction Atlas (MIA) of This DOT

17 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Neoplasm DISZKGEW Definitive Biomarker [1]
Autoimmune hepatitis DISOX03Q Strong Altered Expression [2]
Autosomal dominant optic atrophy, classic form DISXUAV9 Strong Altered Expression [3]
Bronchiolitis DISEE9BG Strong Biomarker [4]
Chronic obstructive pulmonary disease DISQCIRF Strong Altered Expression [5]
Colorectal carcinoma DIS5PYL0 Strong Biomarker [6]
Hepatitis DISXXX35 Strong Altered Expression [2]
Hepatitis A virus infection DISUMFQV Strong Altered Expression [2]
Non-small-cell lung cancer DIS5Y6R9 Strong Altered Expression [5]
Obesity DIS47Y1K Strong Biomarker [7]
Pneumonia DIS8EF3M Strong Biomarker [4]
Pneumonitis DIS88E0K Strong Biomarker [4]
Pulmonary fibrosis DISQKVLA Strong Biomarker [8]
Advanced cancer DISAT1Z9 Limited Biomarker [9]
Autoimmune disease DISORMTM Limited Biomarker [10]
Hepatocellular carcinoma DIS0J828 Limited Biomarker [11]
Nervous system inflammation DISB3X5A Limited Altered Expression [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 17 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
11 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5). [12]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5). [13]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5). [14]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5). [15]
Estradiol DMUNTE3 Approved Estradiol increases the expression of Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5). [16]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5). [17]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide decreases the expression of Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5). [18]
Cannabidiol DM0659E Approved Cannabidiol decreases the expression of Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5). [19]
Clozapine DMFC71L Approved Clozapine decreases the expression of Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5). [19]
Genistein DM0JETC Phase 2/3 Genistein increases the expression of Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5). [16]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5). [21]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5). [20]
------------------------------------------------------------------------------------

References

1 RIPK1-mediated induction of mitophagy compromises the viability of extracellular-matrix-detached cells.Nat Cell Biol. 2018 Mar;20(3):272-284. doi: 10.1038/s41556-018-0034-2. Epub 2018 Feb 19.
2 PGAM5-mediated programmed necrosis of hepatocytes drives acute liver injury.Gut. 2017 Apr;66(4):716-723. doi: 10.1136/gutjnl-2015-311247. Epub 2016 Aug 26.
3 PGAM5 regulates PINK1/Parkin-mediated mitophagy via DRP1 in CCCP-induced mitochondrial dysfunction.Toxicol Lett. 2018 Mar 1;284:120-128. doi: 10.1016/j.toxlet.2017.12.004. Epub 2017 Dec 11.
4 Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway.Nat Immunol. 2018 Feb;19(2):130-140. doi: 10.1038/s41590-017-0013-y. Epub 2017 Dec 18.
5 PGAM5 expression and macrophage signatures in non-small cell lung cancer associated with chronic obstructive pulmonary disease (COPD).BMC Cancer. 2018 Dec 10;18(1):1238. doi: 10.1186/s12885-018-5140-9.
6 The ratio of thioredoxin/Keap1 protein level is a predictor of distant metastasis in colorectal cancer.Biomark Med. 2017 Dec;11(12):1103-1111. doi: 10.2217/bmm-2017-0107. Epub 2017 Oct 20.
7 The Ablation of Mitochondrial Protein Phosphatase Pgam5 Confers Resistance Against Metabolic Stress.EBioMedicine. 2016 Jan 29;5:82-92. doi: 10.1016/j.ebiom.2016.01.031. eCollection 2016 Mar.
8 PGAM5 is a key driver of mitochondrial dysfunction in experimental lung fibrosis.Cell Mol Life Sci. 2019 Dec;76(23):4783-4794. doi: 10.1007/s00018-019-03133-1. Epub 2019 Jun 5.
9 PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis.Autophagy. 2020 Mar;16(3):419-434. doi: 10.1080/15548627.2019.1628520. Epub 2019 Jun 16.
10 Butylphthalide ameliorates experimental autoimmune encephalomyelitis by suppressing PGAM5-induced necroptosis and inflammation in microglia.Biochem Biophys Res Commun. 2018 Feb 26;497(1):80-86. doi: 10.1016/j.bbrc.2018.02.024. Epub 2018 Feb 3.
11 High PGAM5 expression induces chemoresistance by enhancing Bcl-xL-mediated anti-apoptotic signaling and predicts poor prognosis in hepatocellular carcinoma patients.Cell Death Dis. 2018 Sep 24;9(10):991. doi: 10.1038/s41419-018-1017-8.
12 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
13 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
14 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
15 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
16 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
17 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
18 Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
19 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
20 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
21 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.